<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812447172</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812447172</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sinonasal Disorders</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human Inferior Turbinate</article-title>
<subtitle>An Alternative Tissue Source of Multipotent Mesenchymal Stromal Cells</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Hwang</surname><given-names>Se Hwan</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812447172">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Su Young</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-0194599812447172">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname><given-names>Sun Hwa</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-0194599812447172">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Choi</surname><given-names>Mi Young</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-0194599812447172">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kang</surname><given-names>Hyun Wook</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0194599812447172">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Seol</surname><given-names>Young-Joon</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff3-0194599812447172">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname><given-names>Jeong Hun</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff3-0194599812447172">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cho</surname><given-names>Dong-Woo</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0194599812447172">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hong</surname><given-names>Oak Kee</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4-0194599812447172">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rha</surname><given-names>Jong Gu</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff5-0194599812447172">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kim</surname><given-names>Sung Won</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599812447172">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812447172"><label>1</label>Department of Otolaryngology–Head and Neck Surgery, The Catholic University of Korea, College of Medicine, Seoul, Korea</aff>
<aff id="aff2-0194599812447172"><label>2</label>Department of Pathology, The Catholic University of Korea, College of Medicine, Seoul, Korea</aff>
<aff id="aff3-0194599812447172"><label>3</label>Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, Korea</aff>
<aff id="aff4-0194599812447172"><label>4</label>Department of Endocrinology, The Catholic University of Korea, College of Medicine, Seoul, Korea</aff>
<aff id="aff5-0194599812447172"><label>5</label>Department of Obstetrics and Gynecology, The Catholic University of Korea, College of Medicine, Seoul, Korea</aff>
<author-notes>
<corresp id="corresp1-0194599812447172">Sung Won Kim, MD, PhD, Department of Otolaryngology–Head and Neck Surgery, The Catholic University of Korea, College of Medicine, 505 Banpo-dong, Seocho-gu, Seoul, 137-040, Korea Email: <email>kswent@catholic.ac.kr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>3</issue>
<fpage>568</fpage>
<lpage>574</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>1</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>4</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599812447172">
<title>Objective</title>
<p>Mesenchymal stromal cells (MSCs) are multipotent progenitor cells in adult tissues. Current challenges for the clinical application of MSCs include donor site morbidity, which underscores the need to identify alternative sources of MSCs. This study aimed to explore potential new sources of multipotent MSCs for use in tissue regeneration and the functional restoration of organs.</p>
</sec>
<sec id="section2-0194599812447172">
<title>Study Design</title>
<p>Mixed methods research.</p>
</sec>
<sec id="section3-0194599812447172">
<title>Setting</title>
<p>Tertiary care center.</p>
</sec>
<sec id="section4-0194599812447172">
<title>Subjects and Methods</title>
<p>The authors isolated MSCs from human inferior turbinate tissues discarded during turbinate surgery of 10 patients for nasal obstruction. The expression of surface markers for MSCs was assessed by fluorescence-activated cell sorting. The differentiation potential of human turbinate mesenchymal stromal cells (hTMSCs) was analyzed by immunohistochemistry, reverse transcriptase–polymerase chain reaction, and Western blot analysis.</p>
</sec>
<sec id="section5-0194599812447172">
<title>Results</title>
<p>Surface epitope analysis revealed that hTMSCs were negative for CD14, CD19, CD34, and HLA-DR and positive for CD29, CD73, and CD90, representing a characteristic phenotype of MSCs. Extracellular matrices with characteristics of cartilage, bone, and adipose tissue were produced by inducing the chondrogenic, osteogenic, and adipogenic differentiation of hTMSCs, respectively. The expression of neuron-specific markers in hTMSCs was confirmed immunocytochemically.</p>
</sec>
<sec id="section6-0194599812447172">
<title>Conclusion</title>
<p>The hTMSCs represent a new source of multipotent MSCs that are potentially applicable to tissue engineering and regenerative medicine. The availability of differentiated adult cells will allow the development of an effective tissue regeneration method.</p>
</sec>
</abstract>
<kwd-group>
<kwd>inferior turbinate</kwd>
<kwd>turbinate surgery</kwd>
<kwd>mesenchymal stromal cell</kwd>
<kwd>tissue engineering</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Multipotent mesenchymal stromal cells (MSCs) are a population of adult mesenchymal progenitor cells with the capacity to produce progeny that differentiate into cells of various connective tissue lineages.<sup><xref ref-type="bibr" rid="bibr1-0194599812447172">1</xref></sup> MSCs are excellent candidates for cell therapy because they are accessible, their isolation is straightforward, they can be biopreserved with minimal loss of potency,<sup><xref ref-type="bibr" rid="bibr1-0194599812447172">1</xref></sup> and they have shown no adverse reactions to allogeneic versus autologous MSCs transplants.<sup><xref ref-type="bibr" rid="bibr2-0194599812447172">2</xref></sup> Studies have shown that MSCs are present in various tissues and organs, including nervous tissues,<sup><xref ref-type="bibr" rid="bibr3-0194599812447172">3</xref></sup> skin,<sup><xref ref-type="bibr" rid="bibr4-0194599812447172">4</xref></sup> adipose tissue,<sup><xref ref-type="bibr" rid="bibr5-0194599812447172">5</xref></sup> tendons,<sup><xref ref-type="bibr" rid="bibr6-0194599812447172">6</xref></sup> and synovial membranes.<sup><xref ref-type="bibr" rid="bibr7-0194599812447172">7</xref></sup> The best-characterized MSC population is that originating from bone marrow.<sup><xref ref-type="bibr" rid="bibr8-0194599812447172">8</xref></sup> However, for various reasons, including the trauma caused by bone marrow extraction procedures<sup><xref ref-type="bibr" rid="bibr9-0194599812447172">9</xref></sup> and bone marrow–related diseases, much stem cell research has focused on finding alternative sources of adult stem cells that can be isolated noninvasively or by minimally invasive collection procedures.<sup><xref ref-type="bibr" rid="bibr10-0194599812447172">10</xref></sup></p>
<p>Inferior turbinate hypertrophy is one of the most common causes of nasal airway obstruction. Partial inferior turbinate resection is frequently performed to relieve nasal obstruction resulting from turbinate hypertrophy.<sup><xref ref-type="bibr" rid="bibr11-0194599812447172">11</xref></sup> In our preliminary studies, we found that human turbinate fibroblasts could easily be obtained from turbinate tissue discarded during turbinate surgery and that growth in a chondrogenic medium caused human turbinate fibroblasts to acquire a chondrogenic phenotype.<sup><xref ref-type="bibr" rid="bibr12-0194599812447172">12</xref></sup> We sought to validate the hypothesis that the fibroblasts isolated from the inferior turbinate are multipotent MSCs, which we refer to as human turbinate mesenchymal stromal cells (hTMSCs), by characterizing the cells and testing their capacity to differentiate into chondrogenic, osteogenic, adipogenic, and neurogenic cells. Based on these experiments, we aimed to establish these cells as a new source of multipotent MSCs for use in tissue regeneration and the functional restoration of organs.</p>
<sec id="section7-0194599812447172" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section8-0194599812447172">
<title>Cell Isolation</title>
<p>This study was approved by the institutional review board of our university hospital (KC08TISS0341). Informed consent was obtained from the patients before surgery. The same amount (0.0366 g) of the inferior turbinate tissues was obtained from discarded tissue from 10 patients who underwent septoplasty and partial turbinectomy. After hTMSCs from 10 patients were isolated in the same method that was used in a previous study<sup><xref ref-type="bibr" rid="bibr12-0194599812447172">12</xref></sup> (<xref ref-type="fig" rid="fig1-0194599812447172"><bold>Figure 1A</bold></xref>), the cell count was done with an ADAM automated cell counter (Digital Bio, Seoul, Korea). The cells in 3 passages were examined for identifying whether hTMSCs met the criteria of the MSCs, such as adherence to plastic, specific surface antigen expression, and multipotent differentiation potential.<sup><xref ref-type="bibr" rid="bibr13-0194599812447172">13</xref></sup> The cells isolated from a 35-year-old male patient of the study population in 1, 4, 7, 12, 16, and 20 passages were examined for multipassage-related change in immunophenotypical characterization of hTMSCs.</p>
<fig id="fig1-0194599812447172" position="float">
<label>Figure 1.</label>
<caption>
<p>Isolation (A) and fluorescence-activated cell sorting analysis (B) of human turbinate mesenchymal stromal cells.</p>
</caption>
<graphic xlink:href="10.1177_0194599812447172-fig1.tif"/>
</fig>
</sec>
<sec id="section9-0194599812447172">
<title>Characterization by the Analysis of Cell Surface Markers on hTMSCs and Effect of Multipassage on the Immunophenotype of hTMSCs</title>
<p>Flow cytometry on the cell surface markers such as CD14, CD19, CD29, CD34, CD73, CD90, and HLA-DR were conducted and evaluated in an FACS Caliber instrument (BD, Franklin Lakes, New Jersey), and the data were analyzed using Cell Quest software (BD). In addition, the percentage of the expression of specific surface proteins (CD14, CD19, CD34, CD73, CD90, CD105, and HLA-DR) in 6 different passages was assessed by FACS analysis.</p>
</sec>
<sec id="section10-0194599812447172">
<title>Multilineage Differentiation Potential of hTMSCs</title>
<p>To induce chondrogenesis in hTMSCs, we created 3-dimensional cultures in 24-well plates by seeding cells (2 × 10<sup>6</sup>/mL) onto polycaprolactone sponges. Chondrogenic supplements, TGF-β1 (10 ng/mL; Sigma, St Louis, Missouri), and IGF-1 (10 ng/mL; Sigma) were added to Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 nM dexamethasone, 50 µM ascorbic acid-2 phosphate (Sigma), 50 mg/mL insulin-transferrin sodium selenite, 1 mM sodium pyruvate (Gibco, Gaithersburg, Maryland), 40 µM proline, and 2 mM L-glutamine. The medium was replaced every 2 to 3 days. At the end of the second week of culture, the structures were collected and characterized by histological analysis (hematoxylin and eosin stain and toluidine blue stain), immunofluorescence, and Western blot analysis for type II collagen, and by reverse transcriptase–polymerase chain reaction (RT-PCR).</p>
<p>To induce osteogenic differentiation, hTMSCs were seeded in 12-well tissue culture plates (2 × 10<sup>4</sup> cells/well) and incubated in low-glucose DMEM supplemented with 10% FBS, 100 U/mL penicillin, 100 µg/mL streptomycin, 0.1 µM dexamethasone, 50 µM ascorbate-2 phosphate, and 10 mM β-glycerophosphate (all from Sigma). The induction culture was maintained for 4 weeks, with the medium being replaced every 3 days. The cells were analyzed with alkaline phosphatase stain and alizarin red S stain histologically and by RT-PCR.</p>
<p>To induce adipogenic differentiation, hTMSCs were seeded in 6-well plates (3 × 10<sup>3</sup> cells/well), maintained for 3 days in α-MEM (Gibco) supplemented with 10% FBS and antibiotics, and then incubated in α-MEM supplemented with 10 µg/mL insulin, 200 µM indomethacin, 0.1 µM dexamethasone, 0.5 µM 3-isobutyl-1-methylxanthine (all from Sigma), and 10% FBS for 21 days. The cells were stained with Oil Red O and observed under an inverted microscope.</p>
<p>To induce neurogenic differentiation, hTMSCs isolated from turbinate tissue were seeded on Lab-Tek 4-well chamber slides (1 × 10<sup>4</sup> cells/well; Nalgene Nunc International, Rochester, New York) and incubated in a neurobasal medium with neurogenic supplements—10 ng/mL glial-derived neurotrophin factor (Invitrogen, Carlsbad, California), 10 ng/mL brain-derived neurotrophin factor (Invitrogen), 10 ng/mL neurotrophin-3 (Invitrogen), 1 mL B-27 supplement, and 2 mM L-glutamine—and 1% penicillin-streptomycin (Gibco) for 14 days, with medium replacement at 3-day intervals. Cell marker immunolabeling for S-100 (Abcam, Cambridge, Massachusetts), β-tubulin (Abcam), and nestin (Abcam) were observed under a fluorescence microscope (AX70TR62A02, Olympus, Tokyo, Japan).</p>
</sec>
<sec id="section11-0194599812447172">
<title>RNA Extraction and RT-PCR of hTMSCs</title>
<p>Total RNA was extracted from the cells cultured for chondrogenic differentiation and osteogenic differentiation using TRIzol reagent (Invitrogen). The RNA was extracted according to the method recommended by the manufacturer (Kontes, Vineland, New Jersey). For cDNA synthesis, total RNA (2 µg) from each sponge was diluted to a volume of 10 µL in DEPC/DDW and used in a reaction (10 µL) containing 4 µL of 5× first-strand buffer (Invitrogen), 4 µL of DTT (0.1 M; Invitrogen), 1 µL of dNTPs (10 mM; Sigma), 0.5 µg of oligo (dT) 15 primer (Invitrogen), 1 µL of RNase inhibitor (Invitrogen), and 200 units of SuperScript II (Invitrogen). The reaction was incubated at 45°C for 60 minutes. The cDNA was stored at −20°C until needed.</p>
<p>PCR reactions (50 µL) contained GoTaq Flexi DNA polymerase (Promega, Madison, Wisconsin), 4 µL of MgCl<sub>2</sub> (25 mM; Invitrogen), 2 µL of dNTPs (10 mM; Sigma), cDNA template, and primers specific for one of the following: β-actin, aggrecan, type I collagen, type II collagen, osteocalcin, bone sialoprotein (BSP), osterix, bone morphogenetic protein-2 (BMP-2), and runt-related transcription factor 2 (Runx2) (<xref ref-type="table" rid="table1-0194599812447172"><bold>Table 1</bold></xref>). The thermal conditions for PCR amplification were initial denaturation at 94°C for 3 minutes, followed by 35 cycles of 94°C for 30 seconds, 53°C for 30 seconds, and 72°C for 30 seconds, with a final extension at 72°C for 5 minutes. PCR products were separated in 2% agarose (Sigma) gels in 1× Tris-acetate-EDTA buffer containing ethidium bromide.</p>
<table-wrap id="table1-0194599812447172" position="float">
<label>Table 1.</label>
<caption>
<p>Oligonucleotide Primer Sequences Used for Reverse Transcriptase–Polymerase Chain Reaction</p>
</caption>
<graphic alternate-form-of="table1-0194599812447172" xlink:href="10.1177_0194599812447172-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene</th>
<th align="center">Sequence (5′→ 3′)</th>
<th align="center">Product Length</th>
<th align="center">Product Accession
 Numbers</th>
</tr>
</thead>
<tbody>
<tr>
<td>β-actin</td>
<td>GCCCCTCCATCGTCCACCGCGGGCACGAAGGCTCATCATT</td>
<td>493</td>
<td>NM_001101</td>
</tr>
<tr>
<td>Type II collagen</td>
<td>TTTCCCAGGTCAAGATGGTCCTTCAGCACCTGTCTCACCA</td>
<td>377</td>
<td>NM_033150</td>
</tr>
<tr>
<td>Aggrecan</td>
<td>GCAGAGACGCATCTAGAAATTGGTAATTGCAGGGAACATCATT</td>
<td>505</td>
<td>NM_001135</td>
</tr>
<tr>
<td>Type I collagen</td>
<td>GGTAATTGCAGGGAACATCATTAAGAACCCAGCTCGCACATG</td>
<td>599</td>
<td>AB209597</td>
</tr>
<tr>
<td>Osteocalcin</td>
<td>ATGAGAGCCCTCACACTCCTCCGGGCCGTAGAAGCGCCGATA</td>
<td>297</td>
<td>X53698</td>
</tr>
<tr>
<td>BSP</td>
<td>GCTCAGCATTTTGGGAATGGCCTGCATTGGCTCCAGTGACAC</td>
<td>614</td>
<td>J05213</td>
</tr>
<tr>
<td>Osterix</td>
<td>CTTCAGTCTTCCCAACTTCTTACACACAAATTGGGTTAGCTACATCTCTG</td>
<td>486</td>
<td>AF477981</td>
</tr>
<tr>
<td>BMP-2</td>
<td>TTGCGGCTGCTCAGCATGTTCATCTTGCATCTGTTCTCGGAA</td>
<td>315</td>
<td>BC069214</td>
</tr>
<tr>
<td>Runx2</td>
<td>GTGGACGAGGCAAGAGTTTCATGGCAGGTAGGTGTGGTAGTG</td>
<td>698</td>
<td>NM_004348</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812447172">
<p>Abbreviations: BSP, bone sialoprotein; BMP-2, bone morphogenetic protein-2; Runx2, runt-related transcription factor 2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section12-0194599812447172" sec-type="results">
<title>Results</title>
<sec id="section13-0194599812447172">
<title>Isolation and Characterization of hTMSCs by Flow Cytometry</title>
<p>The mean cell counts of hTMSCs at passages 0 and 1 were 23.6 × 10<sup>4</sup> cells and 290 × 10<sup>4</sup> cells, respectively. Cell surface markers of the expanded cells were examined by flow cytometric analysis, and hTMSCs were negative for hematopoietic lineage markers (CD14, CD19, CD34, and HLA-DR) but expressed MSC markers (CD29, CD73, and CD90) (<xref ref-type="fig" rid="fig1-0194599812447172"><bold>Figure 1B</bold></xref>).</p>
<p>All 6 different passage groups of hTMSCs were negative for hematopoietic markers and positive for MSC markers. There are comparable patterns among the 6 groups in the percentage of the expression of specific surface proteins (<xref ref-type="table" rid="table2-0194599812447172"><bold>Table 2</bold></xref>)</p>
<table-wrap id="table2-0194599812447172" position="float">
<label>Table 2.</label>
<caption>
<p>Cellular Passage Number–Related Changes in Immunophenotypic Characterization of hTMSCs</p>
</caption>
<graphic alternate-form-of="table2-0194599812447172" xlink:href="10.1177_0194599812447172-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="6">Passage (%)</th>
</tr>
<tr>
<th align="left">Surface Marker Expression</th>
<th align="center">1</th>
<th align="center">4</th>
<th align="center">7</th>
<th align="center">12</th>
<th align="center">16</th>
<th align="center">20</th>
</tr>
</thead>
<tbody>
<tr>
<td>CD14</td>
<td>0.05</td>
<td>0.04</td>
<td>0.08</td>
<td>0.07</td>
<td>0.02</td>
<td>0.06</td>
</tr>
<tr>
<td>CD19</td>
<td>0.05</td>
<td>0.01</td>
<td>0.03</td>
<td>0.05</td>
<td>0.06</td>
<td>0.00</td>
</tr>
<tr>
<td>CD34</td>
<td>0.06</td>
<td>0.07</td>
<td>0.03</td>
<td>0.00</td>
<td>0.09</td>
<td>0.13</td>
</tr>
<tr>
<td>CD73</td>
<td>99.69</td>
<td>98.40</td>
<td>99.15</td>
<td>93.96</td>
<td>99.06</td>
<td>98.82</td>
</tr>
<tr>
<td>CD90</td>
<td>99.88</td>
<td>99.9</td>
<td>99.87</td>
<td>99.57</td>
<td>99.91</td>
<td>99.76</td>
</tr>
<tr>
<td>CD105</td>
<td>98.78</td>
<td>95.89</td>
<td>96.87</td>
<td>93.31</td>
<td>94.45</td>
<td>94.45</td>
</tr>
<tr>
<td>HLA-DR</td>
<td>0.06</td>
<td>0.02</td>
<td>0.08</td>
<td>0.05</td>
<td>0.03</td>
<td>0.06</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0194599812447172">
<p>Abbreviation: hTMSCs, human turbinate mesenchymal stromal cells.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section14-0194599812447172">
<title>Multilineage Differentiation Potential</title>
<p>The plasticity of the adherent cells derived from turbinate tissue was investigated under conditions favoring chondrogenic, osteogenic, adipogenic, and neurogenic differentiation. To verify chondrogenesis, hTMSCs were grown in 3-dimensional culture systems in which polycaprolactone sponges were used as scaffolds. As shown in <xref ref-type="fig" rid="fig2-0194599812447172"><bold>Figure 2A</bold></xref>-<xref ref-type="fig" rid="fig2-0194599812447172"><bold>B</bold></xref>, the tissue masses formed on the sponges contained spindle-shaped cells in a matrix structure. Metachromatic staining of the matrix was detected within the micronodule-like tissue masses, as evidenced by a red shift with toluidine blue O staining and scattered red dots with immunofluorescence staining. These observations demonstrate the chondroinduction of hTMSCs. Cells exposed to an osteogenic medium showed direct evidence of calcium mineralization, as detected by alizarin red S and alkaline phosphatase staining (<xref ref-type="fig" rid="fig2-0194599812447172"><bold>Figure 2C</bold></xref>-<xref ref-type="fig" rid="fig2-0194599812447172"><bold>D</bold></xref>). After culture in an adipogenic differentiation medium for 2 weeks, the cells acquired an adipocytic phenotype, as evidenced by Oil Red O staining of multisized intracytoplasmic lipid droplets in the induced cells (<xref ref-type="fig" rid="fig2-0194599812447172"><bold>Figure 2E</bold></xref>). Cells subjected to neurogenic induction for 14 days showed the expression of the neuronal markers nestin, S100, and β-tubulin upon immunofluorescence staining with specific antibodies (<xref ref-type="fig" rid="fig2-0194599812447172"><bold>Figure 2F</bold></xref>-<xref ref-type="fig" rid="fig2-0194599812447172"><bold>H</bold></xref>).</p>
<fig id="fig2-0194599812447172" position="float">
<label>Figure 2.</label>
<caption>
<p>Multilineage differentiation. Chondrogenic (A, toluidine blue O staining; B, immunofluorescence staining; magnification ×400), osteogenic (C, alkaline phosphatase staining; D, alizarin red S staining), adipogenic (E; magnification ×400), and neurogenic differentiation (F, nestin; G, s100; H, β-tubulin).</p>
</caption>
<graphic xlink:href="10.1177_0194599812447172-fig2.tif"/>
</fig>
<p>The expression of mRNA of type II collagen and aggrecan, which are chondrogenic differentiation markers, was detected by RT-PCR (<xref ref-type="fig" rid="fig3-0194599812447172"><bold>Figure 3A</bold></xref>), and cartilage-specific type II collagen protein produced by the chondrogenically differentiated hTMSCs was detected by Western blot analysis (<xref ref-type="fig" rid="fig3-0194599812447172"><bold>Figure 3B</bold></xref>). In addition, the expression of mRNAs encoding BSP, Runx2, BMP-2, osterix, and osteocalcin, which are osteogenic differentiation markers, was revealed by RT-PCR analysis (<xref ref-type="fig" rid="fig3-0194599812447172"><bold>Figure 3C</bold></xref>).</p>
<fig id="fig3-0194599812447172" position="float">
<label>Figure 3.</label>
<caption>
<p>Reverse transcriptase–polymerase chain reaction (RT-PCR) analysis (A) and Western blot analysis (B) of chondrogenic differentiation and RT-PCR analysis (C) of osteogenic differentiation. BSP, bone sialoprotein; Runx2, runt-related transcription factor 2; BMP-2, bone morphogenetic protein-2; Osx, osterix, OC, osteocalcin.</p>
</caption>
<graphic xlink:href="10.1177_0194599812447172-fig3.tif"/>
</fig>
<p>Taken together, these results confirm the mesenchymal nature and multipotency of adherent cells isolated from human inferior turbinate tissue.</p>
</sec>
</sec>
<sec id="section15-0194599812447172" sec-type="discussion">
<title>Discussion</title>
<p>The inferior turbinate is an elongated, scroll-like, paired structure situated on the lateral nasal wall. It is composed of a central core of osseous skeleton and a mucosal layer that covers each side of the bone, and it articulates with the nasal surface of the maxilla and the perpendicular plate of the palatine bone.<sup><xref ref-type="bibr" rid="bibr14-0194599812447172">14</xref></sup> The lamina propria extends between the epithelium and the periosteum of the central osseous layer and forms the major portion of the inferior turbinate. The lamina propria is composed of loose connective tissue and a rich network of thin-walled venous sinusoids and contains fibroblasts, macrophages, T and B lymphocytes, plasma cells, granulocytes, and mast cells.<sup><xref ref-type="bibr" rid="bibr5-0194599812447172">5</xref></sup></p>
<p>In a previous investigation, we showed that fibroblasts from inferior turbinate tissue were plastic-adherent and differentiated into chondroid cells when grown in a chondrogenic medium, expressing the chondrogenic markers aggrecan and type II collagen as assessed by RT-PCR,<sup><xref ref-type="bibr" rid="bibr12-0194599812447172">12</xref></sup> and those findings partly satisfied the minimal criteria to define the MSCs. The aim of the present study was to determine whether fibroblasts isolated from the inferior turbinate were multipotent MSCs by means of identifying the cell surface markers and multipotency of the fibroblast. Here, we show that the turbinate-derived cells cultured in FBS expressed CD73 and CD90 but were negative for CD14, CD19, CD34, and HLA-DR. In addition, these cells could be induced to undergo chondrogenic, osteogenic, adipogenic, and neurogenic differentiation. These observations strongly suggest that these cells are MSCs and demonstrate the possibility of using human inferior turbinate tissues removed during turbinate surgery as a source of stem cells.</p>
<p>In view of the yield of MSCs, the cell count of hTMSCs at passages 0 and 1 were measured to be 23.6 × 10<sup>4</sup> cells (6.55 × 10<sup>3</sup> cells/mg) and 29.0 × 10<sup>5</sup> cells (8.05 × 10<sup>4</sup> cells/mg), respectively. Although keeping and counting hTMSCs in the culture by multiple passages would be needed to evaluate the property of the proliferation of the hTMSCs, these results showed approximately 30 times higher yield than adipose-derived MSCs at passage 0 (0.2 – 0.29 × 10<sup>3</sup> cells/mg) that showed no significant differences in the yield, growth kinetics, cell senescence, and gene transduction of MSCs from bone marrow tissue.<sup><xref ref-type="bibr" rid="bibr15-0194599812447172">15</xref>,<xref ref-type="bibr" rid="bibr16-0194599812447172">16</xref></sup> In addition, comparing the proliferation of hTMSCs with that of the bone marrow–derived MSCs,<sup><xref ref-type="bibr" rid="bibr17-0194599812447172">17</xref></sup> hTMSCs exhibited approximately 5 times higher proliferation. Considering the above-mentioned, the inferior turbinate could be considered a relatively high yield source of MSCs. In addition, it was proved that the cell passage number does not affect the characterization of hTMSCs. These results would allow us to expand MSCs to include multipotent MSCs.</p>
<p>Ideally, MSCs for stem cell therapy should be harvested by a simple and minimally invasive procedure from a donor site that heals rapidly without morbidity or scar formation.<sup><xref ref-type="bibr" rid="bibr18-0194599812447172">18</xref></sup> These attributes would be helpful in recruiting MSC donors. The ability to easily isolate MSCs from tissues discarded during surgical procedures would further reduce pain and morbidity in MSC donors and thus increase donor participation. Toward this end, adipose tissue waste from liposuction,<sup><xref ref-type="bibr" rid="bibr19-0194599812447172">19</xref></sup> bone marrow waste from spinal fusion procedures,<sup><xref ref-type="bibr" rid="bibr20-0194599812447172">20</xref></sup> third molar tooth germ tissue from orthodontic surgery,<sup><xref ref-type="bibr" rid="bibr10-0194599812447172">10</xref></sup> and hypertrophic gingival tissue from periodontal surgery<sup><xref ref-type="bibr" rid="bibr21-0194599812447172">21</xref></sup> have been studied as sources of MSCs. In the present study, we show that inferior turbinate tissues removed during turbinate surgery could be used as a source of MSCs. Based on recent data from the National Health Insurance Corporation of Korea, 134,619 turbinate surgeries were performed in 2009 to treat enlarged inferior turbinates. Considering the popularity of turbinate surgery, sufficient turbinate tissue should be available to support seed cell or individual cell banks. Furthermore, the storage and future use of tissue that is normally discarded during surgery may enable the establishment of custom-made tissue and cell banks for patients.</p>
<p>Since 2008, when we introduced the fibroblast of the turbinate that could differentiate chondrogenic phenotype, interest in tissue engineering has increased in the field of otolaryngology, and papers on MSCs isolated from intranasal structures such as nasal mucosa and nasal septal cartilage have been published.<sup><xref ref-type="bibr" rid="bibr15-0194599812447172">15</xref>,<xref ref-type="bibr" rid="bibr16-0194599812447172">16</xref></sup> This article supplements the contents of the previous study on the fibroblasts and describes more characterizations of the fibroblasts. The findings of the present study provide the foundation for expanded research into multipotent MSCs, which would allow the development of an effective tissue regeneration method using adult cells. However, to use these cells for later clinical application, there are several limitations that need clarification and additional experimental details. First, it would be necessary to compare proliferation and differentiation between hTMSCs and MSCs from bone marrow and adipose tissue, which have been widely investigated for their differentiation potential in view of the clinical application. The results previously published for the bone marrow– and adipose tissue–derived MSCs could be used as references and compared to our results about hTMSCs. However, these methods would not identify whether hTMSCs have comparative advantage over the bone marrow– and adipose tissue–derived MSCs. In the future, the harvest of MSCs of various sources in the same person and direct comparison with these MSCs could be performed. Second, although bone marrow–derived MSCs exhibit an age-related decline in life span, proliferation, and osteogenic potential, this study did not investigate the influence of donor age on characterization, proliferation, and differentiation potential of multipotent hTMSCs from patients in different age groups. The results regarding the influence of donor age on hTMSCs would be helpful to allow us to include the donor of the multipotent MSCs. Third, a study concerning the possible hypertrophic conditions associated with turbinate surgery was not performed. Since the MSCs were obtained from surgical preparations that were performed on turbinate hypertrophic tissue, it would be necessary to compare these cells with normal turbinate tissue. Future studies should compare the potential of MSCs of the hypertrophic and contralateral normal inferior turbinate tissues obtained from the same adults. These results would be helpful to reveal the pathogenesis of hypertrophic turbinate and nasal septal deviation associated with the hypertrophic turbinate in cellular level.</p>
<p>In summary, our data show that the fibroblast-like cells we previously isolated from human inferior turbinate tissue are multipotent MSCs. Based on our current understanding of MSC biology, these hTMSCs would appear to represent allogenic MSCs that may be useful for establishing seed cell banks and prefabricated tissues. Future studies should also address the quality of hTMSCs and their suitability for clinical applications.</p>
</sec>
<sec id="section16-0194599812447172" sec-type="conclusions">
<title>Conclusion</title>
<p>This study enables us to prove that hTMSCs can differentiate into other types of adult cells, therefore allowing us to expand the research of the multipotent MSCs that have limited sources of donation. This will allow us to develop an effective tissue-regenerating method with the use of adult cells. Also, the multipotent nature of hTMSCs demonstrated by this research suggests that patients’ cell banks can be established from stromal-cell-rich turbinate tissues that would otherwise be discarded after nasal surgery.</p>
</sec>
<sec id="section17-0194599812447172">
<title>Author Contributors</title>
<p><bold>Se Hwan Hwang</bold>, study conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Su Young Kim</bold>, study conception and design, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Sun Hwa Park</bold>, acquisition of data, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Mi Young Choi</bold>, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Hyun Wook Kang</bold>, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Young-Joon Seol</bold>, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Jeong Hun Park</bold>, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Dong-Woo Cho</bold>, study conception and design, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Oak Kee Hong</bold>, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Jong Gu Rha</bold>, study conception and design, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Sung Won Kim</bold>, study conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revisions, final approval of article.</p>
</sec>
<sec id="section18-0194599812447172">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0011249).</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812447172">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eve</surname><given-names>DJ</given-names></name>
<name><surname>Fillmore</surname><given-names>RW</given-names></name>
<name><surname>Borlongan</surname><given-names>CV</given-names></name>
<name><surname>Sanberg</surname><given-names>PR</given-names></name>
</person-group>. <article-title>Commentary: Stem cell research in “Cell Transplantation”: donor sources, geopolitical influence and transplant types</article-title>. <source>Cell Transplant</source>. <year>2010</year>;<volume>19</volume>:<fpage>1493</fpage>-<lpage>1509</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812447172">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Imanishi</surname><given-names>Y</given-names></name>
<name><surname>Saito</surname><given-names>A</given-names></name>
<name><surname>Komoda</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats</article-title>. <source>J Mol Cell Cardiol</source>. <year>2008</year>;<volume>44</volume>:<fpage>662</fpage>-<lpage>671</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812447172">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>SG</given-names></name>
<name><surname>Shinojima</surname><given-names>N</given-names></name>
<name><surname>Hossain</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Isolation and perivascular localization of mesenchymal stem cells from mouse brain</article-title>. <source>Neurosurgery</source>. <year>2010</year>;<volume>67</volume>:<fpage>711</fpage>-<lpage>720</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812447172">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sellheyer</surname><given-names>K</given-names></name>
<name><surname>Krahl</surname><given-names>D</given-names></name>
</person-group>. <article-title>Skin mesenchymal stem cells: prospects for clinical dermatology</article-title>. <source>J Am Acad Dermatol</source>. <year>2010</year>;<volume>63</volume>:<fpage>859</fpage>-<lpage>865</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812447172">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tucker</surname><given-names>HA</given-names></name>
<name><surname>Bunnell</surname><given-names>BA</given-names></name>
</person-group>. <article-title>Characterization of human adipose-derived stem cells using flow cytometry</article-title>. <source>Methods Mol Biol</source>. <year>2011</year>;<volume>702</volume>:<fpage>121</fpage>-<lpage>131</lpage>.</citation>
</ref>
<ref id="bibr6-0194599812447172">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>TF</given-names></name>
<name><surname>Chen</surname><given-names>YT</given-names></name>
<name><surname>Yang</surname><given-names>TH</given-names></name>
<etal/>
</person-group>. <article-title>Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament</article-title>. <source>Cytotherapy</source>. <year>2008</year>;<volume>10</volume>:<fpage>806</fpage>-<lpage>814</lpage>.</citation>
</ref>
<ref id="bibr7-0194599812447172">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fickert</surname><given-names>S</given-names></name>
<name><surname>Fiedler</surname><given-names>J</given-names></name>
<name><surname>Brenner</surname><given-names>RE</given-names></name>
</person-group>. <article-title>Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2003</year>;<volume>11</volume>:<fpage>790</fpage>-<lpage>800</lpage>.</citation>
</ref>
<ref id="bibr8-0194599812447172">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pelttari</surname><given-names>K</given-names></name>
<name><surname>Steck</surname><given-names>E</given-names></name>
<name><surname>Richter</surname><given-names>W</given-names></name>
</person-group>. <article-title>The use of mesenchymal stem cells for chondrogenesis</article-title>. <source>Injury</source>. <year>2008</year>;<volume>39</volume>(<supplement>suppl 1</supplement>):<fpage>S58</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr9-0194599812447172">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buckner</surname><given-names>CD</given-names></name>
<name><surname>Clift</surname><given-names>RA</given-names></name>
<name><surname>Sanders</surname><given-names>JE</given-names></name>
<etal/>
</person-group>. <article-title>Marrow harvesting from normal donors</article-title>. <source>Blood</source>. <year>1984</year>;<volume>64</volume>:<fpage>630</fpage>-<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr10-0194599812447172">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yalvac</surname><given-names>ME</given-names></name>
<name><surname>Ramazanoglu</surname><given-names>M</given-names></name>
<name><surname>Rizvanov</surname><given-names>AA</given-names></name>
<etal/>
</person-group>. <article-title>Isolation and characterization of stem cells derived from human third molar tooth germs of young adults: implications in neo-vascularization, osteo-, adipo- and neurogenesis</article-title>. <source>Pharmacogenomics J</source>. <year>2010</year>;<volume>10</volume>:<fpage>105</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr11-0194599812447172">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fradis</surname><given-names>M</given-names></name>
<name><surname>Golz</surname><given-names>A</given-names></name>
<name><surname>Danino</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Inferior turbinectomy versus submucosal diathermy for inferior turbinate hypertrophy</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>2000</year>;<volume>109</volume>:<fpage>1040</fpage>-<lpage>1045</lpage>.</citation>
</ref>
<ref id="bibr12-0194599812447172">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SW</given-names></name>
<name><surname>Cho</surname><given-names>JH</given-names></name>
<name><surname>Hong</surname><given-names>MW</given-names></name>
<name><surname>Rhie</surname><given-names>JW</given-names></name>
<name><surname>Yoon</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Induction of chondrogenic differentiation in cultured fibroblasts isolated from the inferior turbinate</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2008</year>;<volume>139</volume>:<fpage>143</fpage>-<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr13-0194599812447172">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dominici</surname><given-names>M</given-names></name>
<name><surname>Le Blanc</surname><given-names>K</given-names></name>
<name><surname>Mueller</surname><given-names>I</given-names></name>
<etal/>
</person-group>. <article-title>Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement</article-title>. <source>Cytotherapy</source>. <year>2006</year>;<volume>8</volume>:<fpage>315</fpage>-<lpage>317</lpage>.</citation>
</ref>
<ref id="bibr14-0194599812447172">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berger</surname><given-names>G</given-names></name>
<name><surname>Balum-Azim</surname><given-names>M</given-names></name>
<name><surname>Ophir</surname><given-names>D</given-names></name>
</person-group>. <article-title>The normal inferior turbinate: histomorphometric analysis and clinical implications</article-title>. <source>Laryngoscope</source>. <year>2003</year>;<volume>113</volume>:<fpage>1192</fpage>-<lpage>1198</lpage>.</citation>
</ref>
<ref id="bibr15-0194599812447172">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jakob</surname><given-names>M</given-names></name>
<name><surname>Hemeda</surname><given-names>H</given-names></name>
<name><surname>Janeschik</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells</article-title>. <source>Stem Cells Dev</source>. <year>2010</year>;<volume>19</volume>:<fpage>635</fpage>-<lpage>644</lpage>.</citation>
</ref>
<ref id="bibr16-0194599812447172">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shafiee</surname><given-names>A</given-names></name>
<name><surname>Kabiri</surname><given-names>M</given-names></name>
<name><surname>Ahmadbeigi</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Nasal septum-derived multipotent progenitors: a potent source for stem cell-based regenerative medicine</article-title>. <source>Stem Cells Dev</source>. <year>2011</year>;<volume>20</volume>:<fpage>2077</fpage>-<lpage>2091</lpage>.</citation>
</ref>
<ref id="bibr17-0194599812447172">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bonab</surname><given-names>MM</given-names></name>
<name><surname>Alimoghaddam</surname><given-names>K</given-names></name>
<name><surname>Talebian</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Aging of mesenchymal stem cell in vitro</article-title>. <source>BMC Cell Biol</source>. <year>2006</year>;<volume>7</volume>:<fpage>14</fpage>.</citation>
</ref>
<ref id="bibr18-0194599812447172">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trotter</surname><given-names>CM</given-names></name>
<name><surname>Hall</surname><given-names>GH</given-names></name>
<name><surname>Salter</surname><given-names>DM</given-names></name>
<name><surname>Wilson</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Histology of mucous membrane of human inferior nasal concha</article-title>. <source>Clin Anat</source>. <year>1990</year>;<volume>3</volume>:<fpage>10</fpage>.</citation>
</ref>
<ref id="bibr19-0194599812447172">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Folgiero</surname><given-names>V</given-names></name>
<name><surname>Migliano</surname><given-names>E</given-names></name>
<name><surname>Tedesco</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Purification and characterization of adipose-derived stem cells from patients with lipoaspirate transplant</article-title>. <source>Cell Transplant</source>. <year>2010</year>;<volume>19</volume>:<fpage>1225</fpage>-<lpage>1235</lpage>.</citation>
</ref>
<ref id="bibr20-0194599812447172">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ichiyanagi</surname><given-names>T</given-names></name>
<name><surname>Anabuki</surname><given-names>K</given-names></name>
<name><surname>Nishijima</surname><given-names>Y</given-names></name>
<name><surname>Ono</surname><given-names>H</given-names></name>
</person-group>. <article-title>Isolation of mesenchymal stem cells from bone marrow wastes of spinal fusion procedure (TLIF) for low back pain patients and preparation of bone dusts for transplantable autologous bone graft with a serum glue</article-title>. <source>Biosci Trends</source>. <year>2010</year>;<volume>4</volume>:<fpage>110</fpage>-<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr21-0194599812447172">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Q</given-names></name>
<name><surname>Shi</surname><given-names>S</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis</article-title>. <source>J Immunol</source>. <year>2009</year>;<volume>183</volume>:<fpage>7787</fpage>-<lpage>7798</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>